Safety, Tolerability and Pharmacokinetics of Oral BI 425809, a Glycine Transporter 1 Inhibitor, in Healthy Male Volunteers: A Partially Randomised, Single-Blind, Placebo-Controlled, First-in-Human Study
Crossref DOI link: https://doi.org/10.1007/s13318-017-0440-z
Published Online: 2017-10-26
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Moschetti, Viktoria http://orcid.org/0000-0001-7632-2397
Desch, Michael
Goetz, Sophia
Liesenfeld, Karl-Heinz
Rosenbrock, Holger
Kammerer, Klaus-Peter
Wunderlich, Glen
Wind, Sven
Funding for this research was provided by:
Boehringer Ingelheim
License valid from 2017-10-26